Thompson Danny L

CIK 00016383631 companyCORALVILLE, IA

SEC Profile

Transactions

Companies

Filings

CIK

0001638363

Recent Transactions

20 trades

Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2019-06-30+8,214→ 31,727 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2019-05-10+8,873→ 23,513 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2019-04-24+30,000→ 30,000 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2018-05-22+15,000→ 15,000 total
Tax Payment
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2018-03-23$7.65/sh−2,026→ 14,640 total
Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2018-03-23−3,333→ 0 total
Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2018-03-23$4.65/sh+3,333→ 16,666 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2017-05-23+10,000→ 10,000 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2016-05-24+10,000→ 10,000 total
Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2016-04-04$4.65/sh+13,333→ 13,333 total
Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2016-04-04−13,333→ 0 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2015-08-25+10,000→ 10,000 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2015-04-21+7,373→ 7,373 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Series A Convertible Preferred Stock
2015-04-21−269,959→ 0 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Series C Convertible Preferred Stock
2015-04-21−12,820→ 0 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Series C Convertible Preferred Stock
2015-04-21−256,410→ 0 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Series A Convertible Preferred Stock
2015-04-21−26,355→ 0 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Series B Convertible Preferred Stock
2015-04-21−161,290→ 0 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2015-04-21+91,687→ 91,687 total
Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Series B Convertible Preferred Stock
2015-04-21−16,129→ 0 total

Companies

ZEVRA THERAPEUTICS, INC.
Director
$ZVRA

Recent Filings

Address

C/O KEMPHARM, INC. 2656 CROSSPARK ROAD, SUITE 100

CORALVILLE, IA, 52241

View on SEC.gov